PURPOSE: For decades of years, hundreds of candidate gene-based association studies explored the relationship between single nucleotide polymorphisms (SNPs) and hepatocellular carcinoma (HCC). There was no systematic review summarized the results of these association studies of candidate SNPs and HCC to date. In order to summarize the results of the association studies, we conducted a concise systematic review. METHODS: By searching Pubmed database before October 2010, we reviewed all the association studies about candidate SNPs and HCC. If the eligible study number on a given SNP was more than three, we conducted a meta-analysis. We reported here only the overall positive-association results with statistical significance and evaluated the reliability of the associations by using false-positive report probability (FPRP) analysis and the Venice guidelines on genetic epidemiology studies. RESULTS: Six SNPs of five genes (rs1800562 of HFE, rs17868323 and rs11692021 of UGT1A7, rs2279744 of MDM2, rs1143627 of IL-1B, and rs4880 of MnSOD) showed overall significant associations with HCC. The eligible number of the studies varied from three to nine. Two SNPs (rs1800562 of HFE and rs2279744 of MDM2) passed the FPRP threshold (FPRP < 0.20). According to the Venice guidelines, the associations between the two SNPs (rs1800562 and rs2279744) and HCC were of moderate evidence. CONCLUSIONS: Two SNPs (rs1800562 of HFE and rs2279744 of MDM2) were associated with HCC with moderate epidemiological evidence and deserve further study and additional biological and clinical assessment.
PURPOSE: For decades of years, hundreds of candidate gene-based association studies explored the relationship between single nucleotide polymorphisms (SNPs) and hepatocellular carcinoma (HCC). There was no systematic review summarized the results of these association studies of candidate SNPs and HCC to date. In order to summarize the results of the association studies, we conducted a concise systematic review. METHODS: By searching Pubmed database before October 2010, we reviewed all the association studies about candidate SNPs and HCC. If the eligible study number on a given SNP was more than three, we conducted a meta-analysis. We reported here only the overall positive-association results with statistical significance and evaluated the reliability of the associations by using false-positive report probability (FPRP) analysis and the Venice guidelines on genetic epidemiology studies. RESULTS: Six SNPs of five genes (rs1800562 of HFE, rs17868323 and rs11692021 of UGT1A7, rs2279744 of MDM2, rs1143627 of IL-1B, and rs4880 of MnSOD) showed overall significant associations with HCC. The eligible number of the studies varied from three to nine. Two SNPs (rs1800562 of HFE and rs2279744 of MDM2) passed the FPRP threshold (FPRP < 0.20). According to the Venice guidelines, the associations between the two SNPs (rs1800562 and rs2279744) and HCC were of moderate evidence. CONCLUSIONS: Two SNPs (rs1800562 of HFE and rs2279744 of MDM2) were associated with HCC with moderate epidemiological evidence and deserve further study and additional biological and clinical assessment.
Authors: G Bougeard; S Baert-Desurmont; I Tournier; S Vasseur; C Martin; L Brugieres; A Chompret; B Bressac-de Paillerets; D Stoppa-Lyonnet; C Bonaiti-Pellie; T Frebourg Journal: J Med Genet Date: 2005-10-28 Impact factor: 6.318
Authors: Laura Silvestri; Laura Sonzogni; Annalisa De Silvestri; Chiara Gritti; Luciana Foti; Claudio Zavaglia; Michela Leveri; Agostino Cividini; Mario U Mondelli; Emilio Civardi; Enrico M Silini Journal: Int J Cancer Date: 2003-04-10 Impact factor: 7.396
Authors: I Stücker; M A Loriot; G N'koutchou; S Cénée; L Bodin; C Mulot; M Gelu-Simeon; L Pelletier; J P Bronowicki; F Degos; P Beaune; P Laurent-Puig; D Hémon; J C Trinchet; G Pelletier Journal: BMC Cancer Date: 2007-11-19 Impact factor: 4.430
Authors: Carla Liaci; Lucia Prandi; Lisa Pavinato; Alfredo Brusco; Mara Maldotti; Ivan Molineris; Salvatore Oliviero; Giorgio R Merlo Journal: Int J Mol Sci Date: 2022-05-30 Impact factor: 6.208
Authors: Jennifer M Noto; Jennifer A Gaddy; Josephine Y Lee; M Blanca Piazuelo; David B Friedman; Daniel C Colvin; Judith Romero-Gallo; Giovanni Suarez; John Loh; James C Slaughter; Shumin Tan; Douglas R Morgan; Keith T Wilson; Luis E Bravo; Pelayo Correa; Timothy L Cover; Manuel R Amieva; Richard M Peek Journal: J Clin Invest Date: 2012-12-21 Impact factor: 14.808
Authors: Valeria Di Vuolo; Luigi Buonaguro; Francesco Izzo; Simona Losito; Gerardo Botti; Franco M Buonaguro; Maria Lina Tornesello Journal: Infect Agent Cancer Date: 2011-08-15 Impact factor: 2.965